Parvoviridae Infections (Parvovirus Infection)

01/01/2013 - "Complete remission (CR) was achieved for 4 of the 5 patients treated with CSP, for 2 of the 3 patients with chronic parvovirus infection treated by immunoglobulin (Ig), and for all 3 patients treated with PSL. "
10/01/2006 - "The role of treatment with immunoglobulins in acute and persistent parvovirus infection is discussed."
06/01/2003 - "Risk of parvovirus infection by immunoglobulin."
01/01/1980 - "Elevated immunoglobulin levels in the diagnosis of intrauterine parvovirus infections in pigs."
02/01/1995 - "Treatment of parvovirus infections among immunocompromised hosts using immunoglobulin has provided the clinician with a useful therapeutic tool but has also highlighted the problems concerning chronic disease states. "

04/01/2022 - "It has been suggested that immunocompromised patients with abnormal antibody production are more susceptible to acquiring a chronic parvovirus infection requiring long-term intravenous immunoglobulin (IVIg) treatment; however, there are no specific guidelines for it. "
01/11/2021 - "Postnatal IVIG treatment for persistent anaemia in neonate due to congenital parvovirus infection."
05/21/1994 - "Intravenous immunoglobulin (IVIG) therapy led to rapid improvement of the systemic vascultis manifestations, clearing of the chronic parvovirus infection, and long-term remission. "
01/11/2021 - "Here, we describe a case of congenital parvovirus infection in a preterm infant complicated by hydrops fetalis and chronic anaemia that responded to postnatal treatment with intravenous immunoglobulin administered on day of life 44. "
04/01/2022 - "A Persistent Parvovirus Infection Causing Anemia in an HIV Patient Requiring Intravenous Immunoglobulin Maintenance Therapy."

03/01/2022 - "Sixty dogs with naturally acquired parvovirus infection, 44 unvaccinated puppies, of which 16 were followed after first and second vaccination, 15 adult dogs, of which 10 were followed also after a booster vaccine, and 9 dogs with distemper virus infection. "
01/01/2017 - "Understanding the role of the NLS in the process of parvovirus infection and its mechanism of nuclear transport will contribute to the development of therapeutic vaccines and novel antiviral medicines."
01/10/1995 - "Our data suggest that synthetic peptides might be useful vaccine reagents for protection against parvovirus infection in humans."

06/01/2013 - "We report a patient with febrile ulceronecrotic Mucha-Habermann disease in a 12-year-old boy in whom the condition was most likely precipitated by parvovirus infection, and he showed a favorable response to a combination of prednisolone with narrow band ultraviolet B (NB-UVB) phototherapy."
09/01/1992 - "She was diagnosed as transverse myelitis with parvovirus infection and was medicated with prednisolone 40-60 mg/day, and improved gradually with the residua of a mild weakness of the legs and hypesthesia on the trunk between the level of Th6 and Th10."

08/01/2010 - "Hematologic improvement in dogs with parvovirus infection treated with recombinant canine granulocyte-colony stimulating factor."

01/10/1995 - "Our data suggest that synthetic peptides might be useful vaccine reagents for protection against parvovirus infection in humans."

01/10/1995 - "Our data suggest that synthetic peptides might be useful vaccine reagents for protection against parvovirus infection in humans."

07/01/2003 - "This study shows that parvoviral DNA can be amplified from feline and canine archival brain tissue and that cerebellar hypoplasia in dogs might be associated with in utero parvovirus infection."
04/01/2015 - "To analyze the diagnostic value of the method for determining the LHP parvovirus B19 DNA in the amniotic fluid, umbilical cord blood of newborns to determine vertical transmission of parvovirus infection when infected mothers B19 during pregnancy."
01/01/2006 - "Among these 20 cases, intrauterine parvovirus infection did exist in 7 pregnant women because parvovirus B19 DNA was detected in the pregnant tissues of them such as placenta tissues, chorionic villi, amniotic fluid, fetal spleen, liver and abdominal fluids."
06/01/1999 - "62 patients (49 LTP, 11 HLTP, 2 HTP) were included in a serological survey and DNA detection by PCR was performed on each serum sample of the first 29 patients; later we performed it only when serology could suggest an acute episode, or when parvovirus infection could be suspected on clinical or biological observations. "
09/01/1996 - "DNA double-strand break repair functions defend against parvovirus infection."

07/01/1989 - "The results of the serological study indicate that parvovirus infection is widespread in Italian herds having 70.3% of sera antibodies to this virus; the most frequent titer detected was 1:8192 or higher. "
06/22/2013 - "No specific clinical sign of parvovirus infection were observed in the vaccinated dogs, nor was (detectable) challenge virus shed in faeces suggesting that antibodies generated contributed sterilising immunity. "
11/01/1994 - "A diagnosis of parvovirus infection was initially rejected due to the lack of specific antibodies and the absence of giant pronormoblasts in the bone marrow. "
09/01/1993 - "Anti-neutrophil antibodies were identified in nine of 12 patients with parvovirus infection. "
09/01/1982 - "Clinical signs were suggestive of parvovirus infection; high serum titers of parvo antibodies were found after the race. "

09/01/1991 - "[Fluorescence serologic and histologic studies of antigen distribution in parvovirus infections in dogs and cats]."
03/30/2023 - "Using rapid antigen tests of fecal samples and conventional PCR, the overall prevalence of parvovirus infection in cats was found to be 35% (35/100) and 43% (43/100), respectively. "
01/01/2020 - "Faecal samples from vaccinated (N17) and unvaccinated or unknown vaccination status (N41) dogs that had clinical signs of parvovirus infection were tested using three different assays of antigen tests, conventional and quantitative PCR tests. "
04/01/2006 - "Development of ELISA using recombinant antigens for specific detection of mouse parvovirus infection."
11/01/1990 - "Antigen distribution in organs of mink with Aleutian disease parvovirus infection."

04/20/2021 - "This is in the context of poor adherence to antiretroviral therapy and significant immunosuppression; there was a delay in diagnosis of chronic parvovirus infection due to attribution of anaemia to HIV. "
09/01/1999 - "This treatment is expensive, therefore accurate and rapid confirmation of parvovirus infection is important in providing appropriate and cost-effective therapy. "
08/01/1997 - "A greater understanding of the natural history of human parvovirus infection is needed prior to deciding the optimum mode of therapy."
06/01/2006 - "This case demonstrates the ability for differential transplacental infection of this virus and the assistance of fetal MCA flow studies to guide therapy in a multiple pregnancy at risk of parvovirus infection."
09/01/1993 - "Nonimmune hydrops fetalis due to maternal parvovirus infection has also been treated successfully with the intravascular transfusion of red cells, whereas fetomaternal hemorrhage has not proved amenable to such therapy. "

11/01/1995 - "We describe persistent parvovirus infection in a 14-year-old boy after HLA-matched sibling allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in second remission."

03/01/2002 - "Serving as a benchmark for future studies, these findings are useful when interpreting epidemiologic data, performing BM transplantation, or considering clinical implications of parvovirus infection."
01/27/1996 - "Since parvoviruses are widespread among laboratory rodents, these findings emphasize the importance of identifying and excluding parvovirus infections in mice used for transplantation studies and in cultures of mouse T lymphocytes."
05/23/2023 - "Moreover, Parvovirus infection is higher at 12 months of follow-up and it decreases at 48 months (40.4% vs. 14%, p = 0.02), while in 24% of grafts, Parvovirus is already detectable at the moment of transplantation. "
05/23/2023 - "Intrarenal Parvovirus infection presents mainly during the first-year post-transplantation; thus, we recommend an active surveillance of donor-specific antibodies (DSA) in patients with intrarenal Parvovirus B19 infection during this period. "

01/01/2019 - "IUETs exhibit a survival rate similar to that of simple intrauterine transfusions in foetal parvovirus infection cases."
11/01/2017 - "Methods This was a single-center retrospective study conducted from January 2005 to December 2016 that assessed patients with singleton pregnancies with fetal parvovirus infection confirmed by a polymerase chain reaction of the amniotic fluid or fetal blood samples who underwent at least one intrauterine transfusion. "
08/01/2017 - "Although the correlation between fetal intracranial anomalies and Parvovirus infection remains unclear, in this population, a detailed evaluation of the brain parenchyma should be considered prior to and after intrauterine blood transfusion."
08/01/2012 - "Recent improvements in diagnosing parvovirus infections and the availability of intrauterine transfusion have reduced the overall rate of fetal loss after maternal exposure. "
01/01/2003 - "With accurate laboratory testing, obstetric sonography, and fetal transfusion, the fetal mortality from parvovirus infection has been reduced considerably, and most pregnancies complicated by maternal parvovirus infection result in healthy outcomes."

08/01/2006 - "In patients with acute leukaemia under chemotherapy who have unexpected anemia, neutropenia and lymphocytosis Parvovirus infection should be considered before a change of chemotherapy protocol. "
01/01/2015 - "In these patients, detected causes of erythroblastopenia were MDS, idiopathic pure red cell aplasia (PRCA), parvovirus infection, post chemotherapy aplasia, plasma proliferative diseases, copper deficiency due to secondary amyloidosis, fever of unknown origin, hemophagocytic syndrome, enteric fever and legionella pneumonia. "
01/01/1999 - "These included chemotherapy-associated pancytopenia (n=22), parvovirus infection (n=5), malignant histiocytosis (n=5), idiopathic aplastic anemia (n=3), sepsis (n=3), myelodysplastic syndrome (n=3), immune-mediated hematologic disease (n=3), lymphoblastic leukemia (n=2), ehrlichiosis (n=2), estrogen toxicity (n=2), and multiple myeloma (n=1). "